Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 204 participants.
Also called NCT03672097
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 204 participants
- Sponsor
- Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company
- Registry
-
NCT03672097
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT03672097. Allocation not applicable; no masking; primary purpose treatment. Start 2018-10-16 (actual); primary completion 2020-08-19 (actual). Results posted on 2021-11-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)
- Condition
- Acute Coronary Syndrome (ACS)
- Intervention (Drug)
- Prasugrel
- Lead sponsor
- Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company
Record details
- Record id
cardio:ct-nct03672097- Content hash
9436ae4010a1f306e6eb75581074dcec1db14be672eb983d84225f7e9fa5e6f1